Healthway Medical Corporation Limited announced unaudited group earnings results for the third quarter and nine months ended September 30, 2018. For the third quarter, the company announced revenue was SGD 27.463 million compared to SGD 27.159 million a year ago. The increase was mainly due to the increase in revenue of SGD 0.8 million in Primary Healthcare segment, offset by decrease in revenue of SGD 0.5 million in Specialist & Wellness Healthcare segment. Loss before income tax was SGD 1.668 million compared to SGD 2.712 million a year ago. Loss for the period attributable to shareholders was SGD 1.628 million compared to SGD 2.820 million a year ago. Basic and diluted loss per ordinary share was SGD 0.0004 compared to SGD 0.0009 a year ago. For the nine months, revenue was SGD 84.767 million compared to SGD 75.784 million a year ago. Loss before income tax was SGD 1.553 million compared to SGD 5.428 million a year ago. Loss for the period attributable to shareholders was SGD 1.434 million compared to SGD 5.948 million a year ago. Basic and diluted loss per ordinary share was SGD 0.0003 compared to SGD 0.002 a year ago.